Delivery Order SPE2DB22D1202-SPE2DB24FUVJ0
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $8,876.81 order is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a specialty pharmaceutical product. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order, valued at $4,567.54, is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, to support military treatment programs and facilities. The delivery order was issued under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $10,149.59 award is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to...
- This is a $10,351.99 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The order has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military...
- This is a $1,263.21 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,564,376,679 units of the ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a total ceiling value of $6,957.55 and a completion date of April 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,454.81 contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a respiratory medication, with a period of performance through January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $10,260.79 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ADVAIR HFA 115-21 MCG INHALER 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a delivery order contract valued at $26,896.77 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) the vendor holds with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award, valued at $3,568.93, is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product. The delivery order was issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUVJ0Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $6,916.44 order is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription pharmaceutical product, to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to provide a comprehensive range of medications and medical supplies to the Department of Defense through December 31, 2025. This contract award did not utilize any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 4/1/24 |